Bayer sells further Covestro stake for 2.2 billion euros

Reuters  |  BERLIN 

(Reuters) - Pharmaceutical group has sold a further stake in company for 2.2 billion euros ($2.64 billion), placing a holding of 14.2 percent via an accelerated bookbuilding process.

Bayer, which is buying Monsanto, raised 1.8 billion euros ($2.15 billion) in January by selling a 10.4 percent stake in

The latest sale of 28.8 million shares to institutional investors valued Covestro stock at 75.50 euros apiece, Bayer said on Friday, bringing the total gains from the sale of Covestro shares to more than 9 billion euros.

"The proceeds from the sale are higher than expected. This will be considered when determining the size of the share capital increase to the proposed acquisition of Monsanto," chief said in a statement.

Bayer now holds 6.8 percent of Covestro shares which it acquired from These will be used to repay an exchangeable bond issued in 2017 that matures in 2020, Bayer said.

BofA Merrill Lynch and acted as joint bookrunners on the placement, which took place late on Thursday.

Covestro shares closed at 76.48 euros on Thursday, while Bayer shares closed at 99.97 euros.

($1 = 0.8344 euros)

(Reporting by Victoria Bryan and Maria Sheahan; Editing by Edmund Blair and Amrutha Gayathri)

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Fri, May 04 2018. 11:40 IST